IPO market

Goldline Pharmaceutical IPO is a SME IPO. Issue size is 12 Cr. Price band is ₹41 to ₹43 per share. Minimum investment is ₹2.58 L. Lot size is 3000 shares. Open from 12 May 2026 to 14 May 2026. on 15 May 2026. Listing on 19 May 2026 at BSE. Managed by Cumulative Capital Pvt.Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, , and listing in one place.
Price band and lot size for Goldline Pharmaceutical IPO. Price band is ₹41 to ₹43 per share. is ₹10 per share. Lot size is 3000 shares. Minimum retail investment from ₹2.58 L.
Official documents: RHP.
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 6,000 | ₹2,58,000 |
| S-HNI (Min) | 3 | 9,000 | ₹3,87,000 |
| S-HNI (UPI) | 3 | 9,000 | ₹3,87,000 |
| S-HNI (Max) | 7 | 21,000 | ₹9,03,000 |
| B-HNI (Min) | 8 | 24,000 | ₹10,32,000 |
Pre-filled: Issue Price = ₹43, Lot Size = 3,000 shares, Listing Price = ₹59.75
| Category | Lots | Investment | At listing | Profit |
|---|---|---|---|---|
| Retail (Min) | 2 | ₹2,58,000 | ₹60 | +₹1,00,500 |
| S-HNI (Min) | 3 | ₹3,87,000 | ₹60 | +₹1,50,750 |
| S-HNI (UPI) | 3 | ₹3,87,000 | ₹60 | +₹1,50,750 |
| S-HNI (Max) | 7 | ₹9,03,000 | ₹60 | +₹3,51,750 |
| B-HNI (Min) | 8 | ₹10,32,000 | ₹60 | +₹4,02,000 |
Profit based on the official listing price for each investor category.
Price band, lot size, and minimum investment—explained.